Глава 8. Экзема

Garritsen F.M., Brouwer M.W.D., Limpens J., Spuls P.I. Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research // Br. J. Dermatol. 2014. Vol. 170. N. 3. P. 501–513. DOI: https://doi.org/10.1111/bjd.12645. PMID: 24116934.

Glatz M., Buchner M., von Bartenwerffer W. et al. Malassezia spp.-specific immunoglobulin E level is a marker for severity of atopic dermatitis in adults // Acta Derm. Venereol. 2015. Vol. 95. N. 2. P. 191–196. DOI: https://doi.org/10.2340/00015555-1864. PMID: 24696225.

Green C., Colquitt J.L., Kirby J., Davidson P. Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use // Br. J. Dermatol. 2005. Vol. 152. N. 1. P. 130–141. DOI: https://doi.org/10.1111/j.1365-2133.2005.06410.x. PMID: 15656813.

Grundmann-Kollmann M., Behrens S., Podda M. et al. Phototherapy for atopic eczema with narrow-band UVB // J. Am. Acad. Dermatol. 1999. Vol. 40. N. 6. Pt. 1. P. 995–997. DOI: https://doi.org/10.1016/s0190-9622(99)70090-3. PMID: 10365933.

Gueniche A., Knaudt B., Schuck E. et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study // Br. J. Dermatol. 2008. Vol. 159. N. 6. P. 1357–1363. DOI: https://doi.org/10.1111/j.1365-2133.2008.08836.x. Epub 2008 Sep 15. PMID: 18795916.

Gupta M., Mahajan V.K., Mehta K.S., Chauhan P.S. Zinc therapy in dermatology: a review // Dermatol. Res. Pract. 2014. Vol. 2014. Article ID 709152. DOI: https://doi.org/10.1155/2014/709152. Epub 2014 Jul 10. PMID: 25120566; PMCID: PMC4120804.

Haneke E. The treatment of atopic dermatis with methylprednisolone aceponate (MPA), a new topical corticosteroid // J. Dermatol. Treat. 1992. Vol. 3. Suppl. 2. P. 13–15. DOI: https://doi.org/10.3109/09546639209092767.

Haslund P., Bangsgaard N., Jarløv J.O. et al. Staphylococcus aureus and hand eczema severity // Br. J. Dermatol. 2009. Vol. 161. N. 4. P. 772–777. DOI: https://doi.org/10.1111/j.1365-2133.2009.09353.x. Epub 2009 Jul 3. PMID: 19575755.

Hjorth N., Schmidt H., Thomsen K. Fusidic acid plus betamethasone in infected or potentially infected eczema // Pharmatherapeutica. 1985. Vol. 4. N. 2. P. 126–131. PMID: 3903779.

Hordinsky M., Fleischer A., Rivers J.K. et al. Efficacy and safety of pimecrolimus cream 1% in mild-to-moderate chronic hand dermatitis: a randomized double-blind trial // Dermatology. 2010. Vol. 221. N. 1. P. 71–77. DOI: https://doi.org/10.1159/000297524. Epub 2010 Jun 8. PMID: 20693804.

Kaffenberger B.H., Mathis J., Zirwas M.J. A retrospective descriptive study of oral azole antifungal agents in patients with patch test-negative head and neck predominant atopic dermatitis // J. Am. Acad. Dermatol. 2014. Vol. 71. N. 3. P. 480–483. DOI: https://doi.org/10.1016/j.jaad.2014.04.045. Epub 2014 Jun 10. PMID: 24925733.

Katsarou A., Makris M., Papagiannaki K. et al. Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study // Eur. J. Dermatol. 2012. Vol. 22. N. 2. P. 192–196. DOI: https://doi.org/10.1684/ejd.2011.1615. PMID: 22407003.

Katsarou A., Papagiannaki K. Topical treatment of hand eczema: calcineurin inhibitors // Textbook of Hand Eczema / Eds. Alikhan A., Lachapelle J.M., Maibach H. Springer, 2014. P. 329–336.

Kawashima M., Tango T., Noguchi T. et al. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study // Br. J. Dermatol. 2003. Vol. 148. N. 6. P. 1212–1221. DOI: https://doi.org/10.1046/j.1365-2133.2003.05293.x. PMID: 12828751.

Lebwohl M. Acitretin in combination with UVB or PUVA // J. Am. Acad. Dermatol. 1999. Vol. 41. N. 3. Pt. 2. P. S22–S24. DOI: https://doi.org/10.1016/s0190-9622(99)70362-2. PMID: 10459143.

Leyden J.J., Kligman A.M. The case for steroid–antibiotic combinations // Br. J. Dermatol. 1977. Vol. 96. N. 2. P. 179–187. DOI: https://doi.org/10.1111/j.1365-2133.1977.tb12541.x. PMID: 843453.

Lodén M., Wirén K., Smerud K.T. et al. The effect of a corticosteroid cream and a barrier-strengthening moisturizer in hand eczema. A double-blind, randomized, prospective, parallel group clinical trial // J. Eur. Acad. Dermatol. Venereol. 2012. Vol. 26. N. 5. P. 597–601. DOI: https://doi.org/10.1111/j.1468-3083.2011.04128.x. Epub 2011 May 24. PMID: 21605175.

Luger T., Paul С. Potential new indications of topical calcineurin inhibitors // Dermatology. 2007. Vol. 215. Suppl. 1. P. 45–54. DOI: https://doi.org/10.1159/000102119. Epub 2007 Dec 18. PMID: 18174692.

Matsuyama T., Ozawa A., Kusakabe Y. et al. Which anti-histamines dermatological specialists select in their therapies for common skin diseases? A practical analysis from multiple clinics // Tokai J. Exp. Clin. Med. 2005. Vol. 30. N. 2. P. 89–95. PMID: 16146198.

Matterne U., Böhmer M.M., Weisshaar E. et al. Oral H1 antihistamines as ‘add-on’ therapy to topical treatment for eczema // Cochrane Database Syst. Rev. 2019. Issue 1. DOI: https://doi.org/10.1002/14651858.CD012167.pub2. PMID: 30666626; PMCID: PMC6360926.

Mernelius S., Carlsson E., Henricson J. et al. Staphylococcus aureus colonization related to severity of hand eczema // Eur. J. Clin. Microbiol. Infect. Dis. 2016. Vol. 35. N. 8. P. 1355–1361. DOI: https://doi.org/10.1007/s10096-016-2672-2. Epub 2016 May 19. PMID: 27193891.

Patrizi A., Raone B., Ravaioli G.M. Management of atopic dermatitis: safety and efficacy of phototherapy // Clin. Cosmet. Investig. Dermatol. 2015. Vol. 2015. N. 8. P. 511–520. DOI: https://doi.org/10.2147/CCID.S87987. PMID: 26491366; PMCID: PMC4599569.

Ramsay C., Savoie J., Gilbert M. et al. The treatment of atopic dermatitis with topical fusidic acid and hydrocortisone acetate // J. Eur. Acad. Dermatol. Venereol. 1996. Vol. 7. Suppl. 1. P. S15–S22. DOI: https://doi.org/10.1016/0926-9959(96)00032-3.

Reynolds N.J., Franklin V., Gray J.C. et al. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial // Lancet. 2001. Vol. 357. N. 9273. P. 2012–2016. DOI: https://doi.org/10.1016/S0140-6736(00)05114-X. PMID: 11438134.

Schlievert P.M., Case L.C., Strandberg K.L. et al. Super-antigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis // Clin. Infect. Dis. 2008. Vol. 46. N. 10. P. 1562–1567. DOI: https://doi.org/10.1086/586746. PMID: 18419342; PMCID: PMC2637450.

Schmitt J., Apfelbacher C.J., Flohr C. Eczema // BMJ Clin. Evid. 2011. 2011; 1716. PMID: 21609512; PMCID: PMC3217753.

Schurmeyer-Horst F., Luger T.A., Bohm M. Long-term efficacy of occlusive therapy with topical pimecrolimus in severe dyshidrosiform hand and foot eczema // Dermatology. 2007. Vol. 214. N. 1. P. 99–100. DOI: https://doi.org/10.1159/000096923. PMID: 17191058.

Sezer E, Etikan I. Local narrowband UVB phototherapy vs local PUVA in the treatment of chronic hand eczema // Photodermatol. Photoimmunol. Photomed. 2007. Vol. 23. N. 1. P. 10–14. DOI: https://doi.org/10.1111/j.1600-0781.2007.00258.x. PMID: 17254029.

Sher L.G., Chang J., Patel I.B. et al. Relieving the pruritus of atopic dermatitis: a meta-analysis // Acta Derm. Venereol. 2012. Vol. 92. N. 5. P. 455–461. DOI: https://doi.org/10.2340/00015555-1360. PMID: 22773026.

Song M., Lee H.-J., Lee W.-K. et al. Acitretin as a therapeutic option for chronic hand eczema // Ann. Dermatol. 2017; 29 (3), 385–387. DOI: https://doi.org/10.5021/ad.2017.29.3.385. Epub 2017 May 11. PMID: 28566929; PMCID: PMC5438959.

Strategos J. Fusidic acid-betamethasone combination in infected eczema: an open, randomized comparison with gentamicin-betamethasone combination // Pharmatherapeutica. 1986. Vol. 4. N. 9. P. 601–606. PMID: 3763654.

Svejgaard E.L., Larsen P.Ø., Deleuran M. et al. Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo // J. Eur. Acad. Dermatol. Venereol. 2004. Vol. 18. N. 4. P. 445–449. DOI: https://doi.org/10.1111/j.1468-3083.2004.00963.x. PMID: 15196159.

Tan J., Maari C., Nigen S. et al. Open-label exploratory study of acitretin for the treatment of sever chronic hand dermatitis // J. Dermatolog. Treat. 2015. Vol. 26. N. 4. P. 373–375. DOI: https://doi.org/10.3109/09546634.2014.952608. PMID: 25102893.

Thestrup-Pedersen K., Andersen K.E., Menné T., Veien N. Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo controlled study // Acta Derm. Venereol. 2001. Vol. 81. N. 5. P. 353–355. DOI: https://doi.org/10.1080/000155501317140089. PMID: 11800144.

van Velsen S.G.A., De Roos M.P., Haeck I.M. et al. The potency of clobetasol propionate: serum levels of clobetasol propionate and adrenal function during therapy with 0.05% clobetasol propionate in patients with severe atopic dermatitis // J. Dermatolog. Treat. 2012. Vol. 23. N. 1. P. 16–20. DOI: https://doi.org/10.3109/09546634.2010.534127. PMID: 21254880.

Wollenberg A., Barbarot S., Bieber T. et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II // J. Eur. Acad.Dermatol. Venereol. 2018. Vol. 32. N. 6. P. 850–878. DOI: https://doi.org/10.1111/jdv.14888. PMID: 29878606.

Wüthrich B, Schmid-Grendelmeier P. The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE-associated («extrinsic») and the nonallergic («intrinsic») AEDS // J. Investig. Allergol. Clin. Immunol. 2003. Vol. 13. N. 1. P. 1–5. PMID: 12861844.